Full Access with Signal8 Pro, $49/mo billed annually.
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 27.19M shares outstanding
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies.
Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia.
The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.
Todd Usen
Chief Executive Officer & Director
Deborah Kaster
Chief Financial Officer & Chief Business Officer
Alex Babkin
Chief Technical Officer
Antwan Gipson
Senior Vice President of Manufacturing & Operations
Employees
41
Country
US
Sector
Healthcare
Website
adagiomedical.com
Loading congressional disclosures…
based on 27.19M shares outstanding
30d Avg
3.38M
60d Avg
1.79M
90d Avg
9.23M